Dr. Herman Yue devises sophisticated intellectual property solutions for clients, particularly within the life sciences and biopharmaceutical space.
Herman leverages his molecular biology expertise and broad-ranging experience across all phases of patent litigation to help clients — ranging from cutting-edge startups to Fortune 50 industry leaders — advance highly technical legal solutions that address:
He engages quickly with clients on both the technical and legal issues that arise in IP matters across a broad range of technologies, including biologics, small molecule pharmaceuticals, gene editing, computer technology, and medical devices. Herman routinely provides analysis in anticipation of litigation and IP due diligence in the context of larger transactions.
Herman maintains an active pro bono practice, including immigration asylum cases and predatory housing matters.
Before practicing law, Herman earned a doctorate in immunology and holds a US patent based on his graduate research on the mammalian TRAIL receptor.
He served as a law clerk to the late Judge Robert W. Sweet of the Southern District of New York.
Herman's representative experience includes representing:
*Matter handled prior to joining Latham
Honors also include FDA Litigation & Enforcement Firm of the Year, Impact Case of the Year, and Impact Deal of the Year.
Latham's Intellectual Property Litigation Practice was honored for securing exceptional trial results this year, including a complete jury trial win for Sarepta Therapeutics and an ITC trial win for Netgear.